Sedana Medical Ab Stock EBITDA
| SEDANA Stock | SEK 11.96 0.30 2.45% |
Sedana Medical AB fundamentals help investors to digest information that contributes to Sedana Medical's financial success or failures. It also enables traders to predict the movement of Sedana Stock. The fundamental analysis module provides a way to measure Sedana Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sedana Medical stock.
Sedana |
Sedana Medical AB Company EBITDA Analysis
Sedana Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Sedana Medical EBITDA | (43.8 M) |
Most of Sedana Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sedana Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Sedana Medical AB reported earnings before interest,tax, depreciation and amortization of (43.8 Million). This is 104.99% lower than that of the Healthcare sector and 109.31% lower than that of the Medical Instruments & Supplies industry. The ebitda for all Sweden stocks is 101.12% higher than that of the company.
Sedana EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sedana Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sedana Medical could also be used in its relative valuation, which is a method of valuing Sedana Medical by comparing valuation metrics of similar companies.Sedana Medical is currently under evaluation in ebitda category among its peers.
Sedana Fundamentals
| Return On Equity | -0.0689 | |||
| Return On Asset | -0.0736 | |||
| Profit Margin | (0.41) % | |||
| Operating Margin | (0.74) % | |||
| Current Valuation | 1.4 B | |||
| Shares Outstanding | 99.34 M | |||
| Shares Owned By Insiders | 34.90 % | |||
| Shares Owned By Institutions | 37.82 % | |||
| Price To Book | 1.94 X | |||
| Price To Sales | 16.06 X | |||
| Revenue | 159.15 M | |||
| Gross Profit | 106.71 M | |||
| EBITDA | (43.8 M) | |||
| Net Income | (57.97 M) | |||
| Cash And Equivalents | 836.18 M | |||
| Cash Per Share | 3.73 X | |||
| Total Debt | 4.64 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 9.83 X | |||
| Book Value Per Share | 10.73 X | |||
| Cash Flow From Operations | (41.22 M) | |||
| Earnings Per Share | (0.72) X | |||
| Target Price | 101.0 | |||
| Number Of Employees | 88 | |||
| Beta | 0.31 | |||
| Market Capitalization | 2.22 B | |||
| Total Asset | 1.17 B | |||
| Net Asset | 1.17 B |
About Sedana Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sedana Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sedana Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sedana Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Sedana Stock
Sedana Medical financial ratios help investors to determine whether Sedana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sedana with respect to the benefits of owning Sedana Medical security.